Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL483 (Atripla, GS-1275, PMP-A, Tenofovir, Truvada) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Core antigen in Hepatitis B virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075091] [UniProtKB: Q03732] | ||||||||
ChEMBL | Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by real time PCR analysis | B | 6.62 | pEC50 | 241.5 | nM | EC50 | Bioorg Med Chem (2017) 25: 1042-1056 [PMID:28082068] |
Human immunodeficiency virus type 1 reverse transcriptase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL247] [UniProtKB: Q72547] | ||||||||
ChEMBL | Binding affinity to ternary complex of HIV1 reverse transcriptase with primer/template in presence of dCTP substrate | B | 5.49 | pKd | 3200 | nM | Kd | Antimicrob Agents Chemother (2007) 51: 2911-2919 [PMID:17517852] |
ChEMBL | Inhibition of HIV1 reverse transcriptase | B | 6.42 | pIC50 | 380 | nM | IC50 | Bioorg Med Chem (2007) 15: 5519-5528 [PMID:17562366] |
ChEMBL | Inhibition of wild type HIV 3B reverse transcriptase in MT2 cells | B | 6.42 | pIC50 | 380 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 1120-1123 [PMID:18164198] |
ChEMBL | Inhibition on HIV1 reverse transcriptase p66/p51 | B | 6.42 | pIC50 | 380 | nM | IC50 | Bioorg Med Chem (2009) 17: 1739-1746 [PMID:19179082] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]